Tiger Shark Cervical Spacer System: FDA Provides Additional 510(k) Clearance

January 25, 2021

Tiger Shark Cervical Spacer System is comprised of titanium alloy and constructed into an anatomical form, complementing the shape of vertebral bodies. The implant features our BioBond™ endplate coverage creating an ideal micro surface for fusion.

The Tiger Shark Cervical Spacer System has experienced great success since inception in 2018. ChoiceSpine is thrilled to announce 510(k) clearance, adding additional footprint sizes that enhance the ability to treat a wider variety of patient anatomies. “We have had great success with our Tiger Shark Cervical Spacer System thus far and we are excited to see where the line extension takes us to support more surgeons and their patients,” said Anderson Collins, Vice President of Business Development and International.

“The additional size offering for Tiger Shark Cervical Spacer System allows me to offer a more bespoke fit for patients with larger vertebral body endplate anatomy,” stated Matthew Hazzard, MD of Northside Hospital in Georgia.

ChoiceSpine LLC, is a spinal device company located in Knoxville, TN and is privately held by Altus Capital Partners. The company prides itself on providing excellent products and exceptional service to meet the needs of their customers. ChoiceSpine offers a breadth of innovative and surgeon focused systems that are designed to be safe, efficient, and easy-to-use. By working closely with physicians and maintaining a service-focused distribution, ChoiceSpine will continue to bring technically superior spinal products to market.

Altus Capital Partners is a private equity firm that makes control investments in middle market manufacturing businesses. We believe that our exclusive focus on manufacturing provides us with a unique understanding of the opportunities and challenges faced by companies in the sector. We utilize a patient, thoughtful investment approach and seek to partner with the management teams of our operating companies to achieve growth. With offices in Wilton, CT and Lincolnshire, IL, Altus Capital Partners has completed 18 platform investments and numerous add on acquisitions since 2003.

Medical Device News Magazinehttps://infomeddnews.com
Medical Device News Magazine provides breaking medical device / biotechnology news. Our subscribers include medical specialists, device industry executives, investors, and other allied health professionals, as well as patients who are interested in researching various medical devices. We hope you find value in our easy-to-read publication and its overall objectives! Medical Device News Magazine is a division of PTM Healthcare Marketing, Inc. Pauline T. Mayer is the managing editor.

More News!

The Evolut ™ FX+ TAVR system leverages market-leading valve performance with addition of larger windows to facilitate coronary access
The study was an analysis of AstraZeneca’s Phase 2 52-Week clinical trial of tralokinumab in patients with Idiopathic Pulmonary Fibrosis (IPF). The patient data from the trial was processed with Brainomix’s e-Lung tool. The tool is uniquely powered by the weighted reticulovascular score (WRVS), a novel biomarker that incorporates reticular opacities and vascular structures of the lung.
“Since the algorithm for matching patients with donors is changing across for all organs, this was a prime time to better understand whether transplant team decisions to accept a donated organ varied by patient race and gender,” she said. “We wanted to understand how the process of receiving a transplant after listing varied by race and gender, and the combination of the two, so that steps can be taken to make that process more equitable," said Khadijah Breathett, MD.
The Mount Sinai study found that primary care physicians’ approach reflects a dearth of evidence-based guidance for lung cancer screening shared decision-making in patients with complex comorbidities
This is the first ever transplantation of a genetically engineered porcine kidney into a living human recipient.

By using this website you agree to accept Medical Device News Magazine Privacy Policy

Exit mobile version